Media headlines about K2M Group Holdings (NASDAQ:KTWO) have been trending somewhat positive this week, Accern Sentiment Analysis reports. Accern identifies positive and negative media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. K2M Group Holdings earned a media sentiment score of 0.19 on Accern’s scale. Accern also gave news articles about the medical device company an impact score of 46.5241420933755 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Several research analysts have issued reports on KTWO shares. Oppenheimer Holdings, Inc. set a $29.00 price objective on K2M Group Holdings and gave the stock a “buy” rating in a research report on Wednesday, August 2nd. JMP Securities restated an “outperform” rating and issued a $30.00 price target (up previously from $27.00) on shares of K2M Group Holdings in a research report on Wednesday, June 28th. Royal Bank Of Canada restated a “buy” rating and issued a $26.00 price target on shares of K2M Group Holdings in a research report on Thursday, July 20th. Needham & Company LLC restated a “buy” rating on shares of K2M Group Holdings in a research report on Wednesday, August 2nd. Finally, BidaskClub upgraded K2M Group Holdings from a “hold” rating to a “buy” rating in a research report on Wednesday, July 19th. Two equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. K2M Group Holdings has a consensus rating of “Buy” and an average price target of $26.25.

Shares of K2M Group Holdings (NASDAQ:KTWO) opened at 23.77 on Friday. K2M Group Holdings has a 1-year low of $15.45 and a 1-year high of $25.99. The company’s 50 day moving average price is $24.01 and its 200-day moving average price is $21.93. The firm’s market cap is $1.03 billion.

K2M Group Holdings (NASDAQ:KTWO) last announced its earnings results on Tuesday, August 1st. The medical device company reported ($0.21) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.22) by $0.01. The company had revenue of $65.70 million for the quarter, compared to analyst estimates of $66.26 million. K2M Group Holdings had a negative return on equity of 15.45% and a negative net margin of 16.21%. K2M Group Holdings’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.27) earnings per share. Equities analysts expect that K2M Group Holdings will post ($0.78) EPS for the current fiscal year.

In other news, insider John Philip Md Kostuik sold 50,000 shares of the business’s stock in a transaction on Thursday, May 25th. The stock was sold at an average price of $22.70, for a total transaction of $1,135,000.00. Following the sale, the insider now directly owns 199,107 shares of the company’s stock, valued at $4,519,728.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Gregory S. Cole sold 42,947 shares of K2M Group Holdings stock in a transaction on Friday, June 16th. The shares were sold at an average price of $22.80, for a total value of $979,191.60. Following the transaction, the chief financial officer now owns 87,425 shares in the company, valued at approximately $1,993,290. The disclosure for this sale can be found here. Insiders have sold 93,903 shares of company stock worth $2,137,451 over the last ninety days. 5.80% of the stock is owned by insiders.

TRADEMARK VIOLATION WARNING: This piece was originally reported by Daily Political and is owned by of Daily Political. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of US & international trademark and copyright law. The correct version of this piece can be read at

About K2M Group Holdings

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.

Insider Buying and Selling by Quarter for K2M Group Holdings (NASDAQ:KTWO)

Receive News & Ratings for K2M Group Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc. and related companies with's FREE daily email newsletter.